Detection of Rheumatoid Arthritis–Interstitial Lung Disease Is Enhanced by Serum BiomarkersTracy J. Doyle, Iván O. Rosas, Avignat S. Patel et al.|American Journal of Respiratory and Critical Care Medicine|2015Cited by 216
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J. Solomon, Marilyn K. Glassberg, Sonye K. Danoff et al.|The Lancet Respiratory Medicine|2022Cited by 211
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic DiseasesSindhu R. Johnson, Jake G. Natalini, Elana J. Bernstein et al.|Arthritis & Rheumatology|2024Cited by 162
Subclinical Interstitial Lung Disease: Why You Should CareTracy J. Doyle, Iván O. Rosas, Gary M. Hunninghake|American Journal of Respiratory and Critical Care Medicine|2012Cited by 155
Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case–Control StudyAnthony J. Esposito, Tracy J. Doyle, Aravind Menon et al.|American Journal of Respiratory and Critical Care Medicine|2020Cited by 150